CMS continues to focus on site-neutral payment policies and keeping payments down for 340B-acquired drugs in the 2021 OPPS proposed rule, released in early August.
The American Medical Association (AMA) on September 8 published two new CPT codes for novel coronavirus (COVID-19)-related services, including one that accounts for additional supplies and clinical staff time used to mitigate spread of the virus.
The American Hospital Association (AHA) asked the U.S. Court of Appeals for the District of Columbia to rehear a July 17 decision in favor of CMS’ site-neutral payment policy, the AHA announced September 1.
CMS is moving forward for E/M changes for physician billing according to the 2021 Medicare Physician Fee Schedule. Read about those changes, as long as a preview of new CPT codes that will be added for 2021.
The Office of Inspector General (OIG) will be reviewing Medicare payments for the novel coronavirus (COVID-19) discharges, according to a recent update to its Work Plan.
A strong revenue cycle is key to staying afloat in the face of evolving challenges. Use these best practices to bolster the accounts receivable process and tap into revenue.
CMS extended the education and operations testing period for the Appropriate Use Criteria (AUC) program for advanced diagnostic imaging through 2021. The education and operations testing period, which started January 1, 2020, was slated to close at the end of the year.
Inpatient novel coronavirus (COVID-19) claims will require a positive viral test result to be eligible for the 20% increase in the MS-DRG weighting factor, effective for admissions on or after September 1.
